MFDS
- Status: likely_approved
🇰🇷 Tarceva in South Korea
Tarceva (erlotinib) regulatory status in South Korea.
Marketing authorisations
MFDS
- Status: likely_approved
MFDS
- Status: likely_approved
MFDS
- Status: likely_approved
MFDS
- Status: likely_approved
MFDS
- Status: likely_approved
Tarceva in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Tarceva approved in South Korea?
Yes. MFDS has authorised it; MFDS has authorised it; MFDS has authorised it.
Who is the marketing authorisation holder for Tarceva in South Korea?
Osi Pharms is the originator. The local marketing authorisation holder may differ — check the official source linked above.